{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:22:01Z","timestamp":1773087721479,"version":"3.50.1"},"reference-count":80,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:00:00Z","timestamp":1698451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Systemic sclerosis (also known as scleroderma) is a chronic fibrosing autoimmune disease with both skin and multisystem organ involvement. Scleroderma has the highest mortality among all rheumatic diseases. The pathophysiology mechanism of systemic sclerosis is a progressive self-amplifying process, which involves widespread microvascular damage, followed by a dysregulation of innate and adaptive immunity and inflammation and diffuse fibrosis of the skin and visceral organs. Fibrosis of internal organs is a hint for systemic sclerosis, moreover associated with interstitial lung disease (SSc-ILD) is a complex process. In order to correlate scientific data from the literature with clinical experience, we present the case of a 56-year-old woman who was diagnosed with systemic sclerosis 16 years ago. The association of numerous comorbidities characterized by a considerable level of seriousness characterizes this case: the highly extensive systemic damage, the cardiovascular impact of the illness, and the existence of severe pulmonary arterial hypertension. The systemic and clinical manifestations, respiratory functional tests, radiological features, and specific therapy are discussed.<\/jats:p>","DOI":"10.3390\/diagnostics13213332","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T05:01:08Z","timestamp":1698555668000},"page":"3332","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Multidisciplinary Approach as a Goal for the Management of Complications in Systemic Scleroderma: A Literature Review and Case Scenario"],"prefix":"10.3390","volume":"13","author":[{"given":"Dariana-Elena","family":"P\u0103tr\u00eenta\u0219u","sequence":"first","affiliation":[{"name":"Pneumology Department, Mures Clinical County Hospital, 540142 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9di Katalin","family":"S\u00e1rk\u00f6zi","sequence":"additional","affiliation":[{"name":"Pneumology Department, Mures Clinical County Hospital, 540142 Targu Mures, Romania"},{"name":"Pneumology Department, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mures, 540139 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugeniu","family":"Lupu\u0219or","sequence":"additional","affiliation":[{"name":"Pneumology Department, Mures Clinical County Hospital, 540142 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina Elena","family":"Vlang\u0103r","sequence":"additional","affiliation":[{"name":"Cardiology Department, Elias University Emergency Hospital, 011461 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gheorghe-Marian","family":"Rotariu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mures, 540139 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ionu\u021b-Alexandru","family":"Ren\u021ba","sequence":"additional","affiliation":[{"name":"Pneumology Department, Mures Clinical County Hospital, 540142 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anda-Nicoleta","family":"Nan","sequence":"additional","affiliation":[{"name":"Pneumology Department, Mures Clinical County Hospital, 540142 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7785-0121","authenticated-orcid":false,"given":"Corina Eugenia","family":"Budin","sequence":"additional","affiliation":[{"name":"Pneumology Department, Mures Clinical County Hospital, 540142 Targu Mures, Romania"},{"name":"Pathophysiology Department, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mures, 540139 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/kjm2.12505","article-title":"Pathophysiology of systemic sclerosis (scleroderma)","volume":"38","author":"Rosendahl","year":"2022","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Gumkowska-Sroka, O., Kotyla, K., Mojs, E., Palka, K., and Kotyla, P. (2023). Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis. Pharmaceuticals, 16.","DOI":"10.20944\/preprints202306.0143.v1"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/BOR.0000000000000592","article-title":"Management of systemic sclerosis-associated interstitial lung disease","volume":"31","author":"Roofeh","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_5","first-page":"e329","article-title":"Interstitial lung disease in systemic sclerosis","volume":"43","author":"Wells","year":"2014","journal-title":"Eur. Respir. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.12968\/hmed.2019.80.9.530","article-title":"Systemic sclerosis","volume":"80","author":"Hughes","year":"2019","journal-title":"Br. J. Hosp. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2021.10.065","article-title":"Systemic sclerosis in adults. Part I: Clinical features and pathogenesis","volume":"87","author":"Jerjen","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: Current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2010.104","article-title":"Assessing microvascular changes in systemic sclerosis diagnosis and management","volume":"6","author":"Cutolo","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/ITT.S82037","article-title":"Current perspectives on the immunopathogenesis of systemic sclerosis","volume":"5","author":"Fuschiotti","year":"2016","journal-title":"ImmunoTargets Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fphar.2019.00360","article-title":"Innovations in the Assessment of Primary and Secondary Raynaud\u2019s Phenomenon","volume":"10","author":"Ruaro","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Almaabdi, K., Ahmad, Z., and Johnson, S.R. (2023). Advanced Autoantibody Testing in Systemic Sclerosis. Diagnostics, 13.","DOI":"10.3390\/diagnostics13050851"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3899\/jrheum.121089","article-title":"Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis","volume":"40","author":"Sulli","year":"2013","journal-title":"J. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"154635","DOI":"10.1016\/j.cyto.2018.12.018","article-title":"Type I interferon dysregulation in Systemic Sclerosis","volume":"132","author":"Skaug","year":"2019","journal-title":"Cytokine"},{"key":"ref_16","first-page":"1911","article-title":"Systemic sclerosis: One year in review 2022","volume":"40","author":"Lepri","year":"2022","journal-title":"Rheumatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-1382-5_1","article-title":"50 years of myofibroblasts: How the myofibroblast concept evolved","volume":"Volume 2299","author":"Gabbiani","year":"2021","journal-title":"Methods in Molecular Biology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1002\/art.23134","article-title":"Endothelin is a downstream mediator of profibrotic responses to transforming growth factor \u03b2 in human lung fibroblasts","volume":"56","author":"Kennedy","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: One function, multiple origins","volume":"170","author":"Hinz","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.41267","article-title":"Pathogenic Activation of Mesenchymal Stem Cells Is Induced by the Disease Microenvironment in Systemic Sclerosis","volume":"72","author":"Taki","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11926-017-0627-y","article-title":"Interfacial adipose tissue in systemic sclerosis","volume":"19","author":"Kruglikov","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semarthrit.2017.02.006","article-title":"Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis","volume":"47","author":"Avouac","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e000782","DOI":"10.1136\/rmdopen-2018-000782","article-title":"Systemic sclerosis: State of the art on clinical practice guidelines","volume":"4","author":"Smith","year":"2018","journal-title":"RMD Open"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrrheum.2017.95","article-title":"Managing rheumatic and musculoskeletal diseases\u2014Past, present and future","volume":"13","author":"Burmester","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: An American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_27","first-page":"CR615-21","article-title":"A proposal of criteria for the classification of systemic sclerosis","volume":"10","author":"Nadashkevich","year":"2004","journal-title":"Med. Sci. Monit."},{"key":"ref_28","unstructured":"Simone, P., and Ditto, M.C. (2017). Systemic Sclerosis, InTech."},{"key":"ref_29","first-page":"202","article-title":"Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis","volume":"15","author":"Leroy","year":"1988","journal-title":"J. Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2014.22","article-title":"Connective tissue diseases: Systemic sclerosis: Beyond limited and diffuse subsets?","volume":"10","author":"Varga","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"101428","DOI":"10.1016\/j.berh.2019.101428","article-title":"Very early systemic sclerosis","volume":"33","year":"2019","journal-title":"Best Pr. Res. Clin. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: Results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41584-023-00909-5","article-title":"State-of-the-art evidence in the treatment of systemic sclerosis","volume":"19","author":"Pope","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J. Scleroderma Relat. Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/rheumatology\/kew047","article-title":"Digital ulcers in systemic sclerosis","volume":"56","author":"Hughes","year":"2017","journal-title":"Rheumatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semarthrit.2016.05.001","article-title":"Differential diagnosis of critical digital ischemia in systemic sclerosis: Report of five cases and review of the literature","volume":"46","author":"Sharp","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"iii45","DOI":"10.1093\/rheumatology\/kep110","article-title":"Cardiac complications of systemic sclerosis","volume":"48","author":"Kahan","year":"2006","journal-title":"Rheumatology"},{"key":"ref_38","first-page":"1188","article-title":"The risk of cardiovascular disease in systemic sclerosis: A population-based cohort study","volume":"72","author":"Man","year":"2013","journal-title":"Rheumatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","article-title":"Systemic sclerosis-associated interstitial lung disease","volume":"8","author":"Perelas","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/art.39405","article-title":"Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease","volume":"67","author":"Suliman","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/art.41933","article-title":"Systemic Sclerosis\u2013Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration\u2013Approved Therapies in Clinical Practice","volume":"74","author":"Khanna","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12931-022-02292-3","article-title":"Expert consensus on the management of systemic sclerosis-associated interstitial lung disease","volume":"24","author":"Rahaghi","year":"2023","journal-title":"Respir. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.resinv.2016.05.004","article-title":"A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease","volume":"54","author":"Okamoto","year":"2016","journal-title":"Respir. Investig."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3899\/jrheum.121390","article-title":"Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis","volume":"40","author":"Molberg","year":"2013","journal-title":"J. Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e31780","DOI":"10.1097\/MD.0000000000031780","article-title":"Gastrointestinal involvement in systemic sclerosis: An updated review","volume":"101","author":"Nassar","year":"2022","journal-title":"Medicine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/s00296-011-1988-6","article-title":"Profile of gastrointestinal involvement in patients with systemic sclerosis","volume":"32","author":"Schmeiser","year":"2012","journal-title":"Rheumatol. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s00296-006-0146-z","article-title":"Gastrointestinal manifestations in Hungarian scleroderma patients","volume":"26","author":"Szamosi","year":"2006","journal-title":"Rheumatol. Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/2397198318758607","article-title":"Kidney involvement in systemic sclerosis: From pathogenesis to treatment","volume":"3","author":"Bruni","year":"2018","journal-title":"J. Scleroderma Relat. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.lpm.2014.02.031","article-title":"Kidney involvement in systemic sclerosis","volume":"43","author":"Steen","year":"2014","journal-title":"Presse Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","article-title":"Long-term outcomes of scleroderma renal crisis","volume":"133","author":"Steen","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.semarthrit.2019.11.003","article-title":"Musculoskeletal hand involvement in systemic sclerosis","volume":"50","author":"Sandler","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3899\/jrheum.091165","article-title":"Characteristics of Joint Involvement and Relationships with Systemic Inflammation in Systemic Sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database","volume":"37","author":"Avouac","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0363-5023(88)80009-1","article-title":"Carpal tunnel syndrome as the initial manifestation of scleroderma","volume":"13","author":"Barr","year":"1988","journal-title":"J. Hand Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"102211","DOI":"10.1016\/j.coph.2022.102211","article-title":"Current advances in the treatment of systemic sclerosis","volume":"64","author":"Bukiri","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/BOR.0000000000000711","article-title":"Management of systemic sclerosis: The first five years","volume":"32","author":"Roofeh","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.41055","article-title":"Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial","volume":"72","author":"Khanna","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.semarthrit.2015.07.002","article-title":"A right ventricular diastolic impairment is common in systemic sclerosis and is associated with other target-organ damage","volume":"45","author":"Meune","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/BOR.0000000000000604","article-title":"Management of scleroderma renal crisis","volume":"31","author":"Nagaraja","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2021.10.066","article-title":"Systemic sclerosis in adults. Part II: Management and therapeutics","volume":"87","author":"Jerjen","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/BOR.0000000000000795","article-title":"Treatment for systemic sclerosis-associated interstitial lung disease","volume":"33","author":"Roofeh","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): A randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Budin, C.E., Cocuz, I.G., Sab\u0103u, A.H., Niculescu, R., Ianosi, I.R., Ioan, V., and Cotoi, O.S. (2022). Pulmonary Fibrosis Related to Amiodarone\u2014Is It a Standard Pathophysiological Pattern? A Case-Based Literature Review. Diagnostics, 12.","DOI":"10.3390\/diagnostics12123217"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.40441","article-title":"Screening High-Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists","volume":"70","author":"Bernstein","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3899\/jrheum.100956","article-title":"Late-age Onset Systemic Sclerosis","volume":"38","author":"Manno","year":"2011","journal-title":"J. Rheumatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/rheumatology\/keaa127","article-title":"Older age onset of systemic sclerosis\u2014Accelerated disease progression in all disease subsets","volume":"59","author":"Moinzadeh","year":"2020","journal-title":"Rheumatology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/kez486","article-title":"Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study","volume":"59","author":"Jaeger","year":"2019","journal-title":"Rheumatology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13075-019-2078-5","article-title":"High risk of gastrointestinal hemorrhage in patients with systemic sclerosis","volume":"21","author":"Lin","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2017.09.002","article-title":"Gastrointestinal and hepatic disease in systemic sclerosis","volume":"44","author":"Frech","year":"2018","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"190109","DOI":"10.1183\/16000617.0109-2019","article-title":"Treatment of progressive fibrosing interstitial lung diseases: A milestone in the management of interstitial lung diseases","volume":"28","author":"Cottin","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s10067-019-04847-0","article-title":"A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis","volume":"39","author":"Chen","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"ref_73","unstructured":"World Health Organization (2023, October 11). WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level: Summary Meeting Report, Available online: https:\/\/frax.shef.ac.uk\/FRAX\/pdfs\/WHO_Technical_Report.pdf."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"9782994","DOI":"10.1155\/2021\/9782994","article-title":"Role of Vitamin D in Systemic Sclerosis: A Systematic Literature Review","volume":"2021","author":"Diaconu","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-2600(20)30330-1","article-title":"Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: A subgroup analysis of the SENSCIS trial","volume":"9","author":"Highland","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_76","first-page":"283","article-title":"Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention","volume":"11","author":"Fischer","year":"2019","journal-title":"Open Access Rheumatol. Res. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/S2665-9913(19)30144-4","article-title":"The indentification and management of interstitial lung disease in systemic sclerosis: Evi-dence-based European consensus statements","volume":"2","author":"Maher","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.40130","article-title":"Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis","volume":"69","author":"Goh","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1378\/chest.15-0003","article-title":"Predicting Mortality in Systemic Sclerosis-Associated Interstitial Lung Disease Using Risk Prediction Models Derived from Idiopathic Pulmonary Fibrosis","volume":"148","author":"Ryerson","year":"2015","journal-title":"Chest"},{"key":"ref_80","first-page":"S142","article-title":"Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease","volume":"33","author":"Rizzi","year":"2015","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/21\/3332\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:13:34Z","timestamp":1760130814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/21\/3332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,28]]},"references-count":80,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["diagnostics13213332"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13213332","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,28]]}}}